Zhao Cui

ORCID: 0000-0002-5837-1926

Also affiliated with Ministry of Education of the People's Republic of China, Peking University, Peking University First Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis”.

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

Nature Communications(2020)10.1038/s41467-020-15383-w

N/A

4.6DataRank · unranked

223 citations

Lili Liu, Nikol Mladkova, Yifu Li, Hong Ren, Weiming Wang +95 more

Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture’s and Alport diseases

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100590

N/A

1.0DataRank · unranked

32 citations

Harald Seeger, Vadim Pedchenko, Sergei Chetyrkin, Carsten Bergmann, Dale R. Abrahamson +25 more

Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf153

N/A

0.320DataRank · unranked

4 citations

Beining Wang, Xiao Jia, Zhao Cui, Xiaojuan Yu, Nan Jiang +3 more

The Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: Updated Results of an Ongoing, Multicenter, Randomized, Open-Label Phase 1b/2 Trial

Journal of the American Society of Nephrology(2023)10.1681/asn.20233411s1988a

N/A

0DataRank · unranked

0 citations

Zhao Cui, Alexandra P. Lewis, Hua Zhou, Hong L. Lin, Guangqun Xing +23 more

#3776 THE TYPE Ⅱ ANTI-CD20 MONOCLONAL ANTIBODY MIL62 OR CYCLOSPORINE IN CHINESE PRIMARY MEMBRANOUS NEPHROPATHY: PRELIMINARY RESULTS OF A PHASE ⅠB/Ⅱ TRIAL

Nephrology Dialysis Transplantation(2023)10.1093/ndt/gfad063c_3776

N/A

0DataRank · unranked

0 citations

Yimiao Zhang, Alexandra P. Lewis, Hua Zhou, Hongli Lin, Guangqun Xing +21 more

Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial

Journal of the American Society of Nephrology(2024)10.1681/asn.2024yaqz098x

N/A

0DataRank · unranked

0 citations

Alexandra P. Lewis, Hua Zhou, Hong Li Lin, Guangqun Xing, Wei Chen +22 more

Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease

Kidney International(2023)10.1016/j.kint.2023.07.023

N/A

0DataRank · unranked

19 citations

Congrong Shen, Xiaoyu Jia, Meng Tan, Xuefen Yang, Zhao Cui +3 more